trial · primary record
CPL304110
Gastric Cancer
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 37 |
| Primary completion | 2025-01-23 |
| Primary endpoint | Maximum tolerated dose (MTD) |
| Registry ID | NCT04149691 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:05.560Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04149691
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.